Functional Medicine for Menopause: What Labs and Root-Cause Care Can and Cannot Do



Dr. Shweta Patel, Board-Certified OB/GYN

Board-certified OB/GYN • U.S. Navy veteran (13 years) • Author, The Book of Hormones • Founder, Gaya Wellness

Key Finding: Functional medicine gets attention because too many women are dismissed during perimenopause and menopause. That frustration is real. But broad lab panels, detox language, and “root-cause” supplement stacks cannot replace evidence-based menopause care. Current guidance from The Menopause Society, ACOG, the Endocrine Society, and the FDA points to a more careful standard: symptoms, timeline, risk, targeted labs, treatment eligibility, and physician-managed follow-up.

Many women do not look for functional medicine because they want fringe care. They look for it because conventional care has often failed them. They were told their hot flashes were stress. Their insomnia was anxiety. Their weight gain was aging. Their painful sex was normal. Their low libido was marriage. Their mood changes were a character flaw. Then someone finally says, “Let’s look deeper,” and it feels like oxygen.

I understand why that message lands. Women deserve whole-person care. They deserve a clinician who asks about sleep, nutrition, alcohol, stress, thyroid symptoms, medications, glucose, libido, vaginal pain, urinary symptoms, and whether they still feel like themselves.

But here is the part I will not soften: being heard is not the same as being treated well. A long lab panel is not a diagnosis. A root-cause story is not automatically evidence. And a supplement plan is not safer because it sounds natural.

The standard should be better than both extremes. Women do not need dismissive conventional care, and they do not need expensive guesswork. They need physician-managed, evidence-based, whole-person menopause care.

Why Functional Medicine Became So Appealing

Functional medicine often attracts women in midlife because it validates complexity. Estrogen and progesterone decline intersect with sleep, temperature regulation, metabolism, bone, muscle, brain, bladder, vaginal tissue, mood, and cardiovascular risk. A 10-minute visit can miss that picture.

The appeal is also emotional. Many women have been told that symptoms are normal, even when those symptoms are destroying quality of life. Normal does not mean acceptable. It is common to have hot flashes, night sweats, insomnia, vaginal dryness, urinary urgency, and body-composition changes during menopause. It is not good medicine to ignore them.

Where functional medicine can help is in the insistence that the body is connected. Sleep affects insulin sensitivity. Alcohol can worsen vasomotor symptoms and sleep fragmentation. Low protein and low resistance training can accelerate muscle loss. Thyroid disease, anemia, depression, sleep apnea, and medication side effects can mimic or amplify menopause symptoms.

Labs Are Tools, Not Truth Machines

Targeted labs can be useful in menopause care. I may check thyroid function when symptoms overlap. I may look at A1c, fasting glucose, lipids, liver and kidney markers, blood count, ferritin, B12, vitamin D, or inflammatory context depending on the patient. Labs can uncover diabetes risk, anemia, thyroid disease, medication safety issues, bone-health concerns, and cardiometabolic risk.

But menopause is not usually solved by ordering every hormone marker available. In many women over 45, perimenopause and menopause are diagnosed mainly from age, cycle pattern, and symptoms because hormone levels fluctuate. A single FSH, estradiol, progesterone, or cortisol result may describe one moment, not the whole clinical story.

The Endocrine Society has warned that saliva-based hormone customization claims are not supported by strong clinical evidence, and that compounded hormone products can vary in dose and purity. Its position statement notes that many FDA-approved estradiol and progesterone products are already structurally identical to hormones made by the body, with stronger manufacturing oversight than custom-compounded products.

That does not mean labs are useless. It means the question has to come first. Are we diagnosing menopause? Assessing safety before treatment? Investigating fatigue? Evaluating metabolic risk? Monitoring thyroid disease? Looking for anemia? The right lab is the one that changes the plan.

Root Cause Language Can Help or Harm

“Root cause” can be a useful phrase when it pushes clinicians to ask why a symptom is happening. If a woman has fatigue, the root cause could be night sweats, sleep apnea, hypothyroidism, anemia, depression, under-eating, overtraining, alcohol, medication effects, or estrogen withdrawal. That is a real diagnostic process.

But root-cause language can also become a trap. Sometimes the root cause of menopause symptoms is menopause. Ovarian estrogen production changes. Progesterone production changes. Vaginal and urinary tissues become estrogen-sensitive. Temperature regulation shifts. Bone loss can accelerate. The answer is not always to find a deeper toxin, parasite, food intolerance, or adrenal story.

Women are often told they need to heal their gut, lower cortisol, balance insulin, and reduce inflammation before they can address hormones. Some of those areas may matter. But when hot flashes, night sweats, genitourinary symptoms, or rapid bone loss are clearly related to menopause, delaying treatment can prolong suffering.

This is why I prefer a layered model. First, name the symptom. Second, define the likely driver. Third, look for overlapping medical issues. Fourth, discuss evidence-based options. Fifth, monitor response. That process can include nutrition, strength training, sleep repair, alcohol reduction, metabolic care, and stress physiology. It can also include hormone therapy when appropriate.

What Evidence-Based Menopause Care Actually Says

The 2022 Menopause Society hormone therapy position statement remains one of the most important guidance documents for this conversation. It describes hormone therapy as the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause in appropriate candidates, and it emphasizes individualization by age, time since menopause, route, dose, duration, and risk profile.

The benefit-risk profile is generally more favorable for healthy symptomatic women younger than 60 or within 10 years of menopause who have no contraindications. For women who start systemic therapy after age 60 or more than 10 years from menopause, the risk-benefit conversation changes because absolute risks are higher. That is not hormone fear. That is medicine.

The American College of Obstetricians and Gynecologists also describes systemic estrogen as the best treatment for hot flashes and night sweats, and it recommends FDA-approved hormone therapy over compounded hormone therapy. ACOG’s 2023 clinical consensus on compounded bioidentical menopausal hormone therapy reinforces the same practical point: compounded products may be appropriate in limited circumstances, but they should not be treated as safer, more effective, or better regulated than approved options.

The Endocrine Society position statement is especially relevant for women drawn to functional medicine clinics that market compounded hormones, pellet therapy, or saliva-guided dosing. The issue is not whether estradiol or progesterone can be effective. They can be. The issue is whether the formulation, dose, monitoring, and claims are supported by evidence and oversight.

The FDA’s February 12, 2026 menopausal hormone therapy labeling update clarified risk language for several products. I read that as part of a broader correction away from outdated fear and toward individualized counseling. It does not mean hormones are risk-free. It means women deserve current information, not twenty-year-old panic or internet certainty.

What Functional Medicine Often Gets Right

Functional medicine often gets one thing right: symptoms should be connected. A woman with perimenopause symptoms may also have insulin resistance, poor sleep, alcohol-triggered hot flashes, inadequate protein, low muscle mass, thyroid disease, trauma-driven hyperarousal, or medication side effects. If a clinician only asks, “Do you want hormones?” the visit is incomplete.

Whole-person care should include nutrition. Protein matters after menopause because muscle becomes harder to maintain. Fiber matters because glucose, cholesterol, gut motility, and satiety matter. Strength training matters because muscle protects metabolic health, bones, balance, and long-term function. Sleep matters because broken sleep worsens mood, appetite, insulin sensitivity, and recovery.

Functional medicine also tends to ask about environmental load, stress load, and inflammation. Those conversations can be useful when they are grounded in evidence and translated into reasonable steps: reduce alcohol, stop smoking, build muscle, treat sleep apnea, review medications, address blood pressure, manage glucose, treat vaginal pain, and screen appropriately.

At Gaya, this is why menopause care connects with metabolic health, stubborn weight gain, women’s health, and Her Longevity. The body is connected. The plan still has to be medically disciplined.

What It Often Gets Wrong

The most common problem is over-testing without a decision pathway. If a clinic orders a large panel but cannot tell you which result would change diagnosis, treatment, safety monitoring, or referral, the test may be more performance than medicine.

The second problem is supplement substitution. Magnesium, creatine, omega-3s, vitamin D, protein, fiber, and selected botanicals may have a place for some women. But supplements do not replace evaluation for severe vasomotor symptoms, genitourinary syndrome, postmenopausal bleeding, osteoporosis risk, recurrent urinary symptoms, sleep apnea, thyroid disease, or depression.

The third problem is hormone marketing. “Bioidentical” is often used as if it means safer. In reality, many FDA-approved estradiol and progesterone products are bioidentical in structure. The difference is not natural versus synthetic. The difference is regulated versus custom-compounded, tested versus assumed, monitored versus marketed.

The fourth problem is blame. Women are told that if they detoxed better, ate cleaner, managed stress, fixed their gut, or regulated cortisol, they would feel fine. That can become another version of dismissal. Menopause is not a moral test.

What a Better Menopause Visit Should Include

A better visit starts with the story. When did your cycles change? When was the final menstrual period? Was menopause natural, surgical, medication-related, or early? Do you still have a uterus? Any bleeding after menopause? Any history of clot, stroke, heart disease, breast cancer, liver disease, migraine aura, uncontrolled blood pressure, or unexplained pelvic symptoms?

Then we identify the symptom cluster. Vasomotor symptoms include hot flashes and night sweats. Genitourinary syndrome may include vaginal dryness, burning, painful sex, urinary urgency, recurrent urinary discomfort, and tissue fragility. Metabolic changes may include abdominal weight gain, insulin resistance, lipid changes, cravings, and reduced muscle. Mood and cognitive symptoms may be driven by hormones, sleep disruption, stress, depression, medications, or several factors together.

Then we decide what belongs in the workup. Targeted labs may be appropriate. Bone-density screening may be needed. Pelvic evaluation may be necessary for bleeding or pain. Cardiometabolic markers may matter more than another estrogen level. If symptoms are classic and the patient is an appropriate candidate, care should not be delayed because a hormone panel does not look dramatic.

This is the frame behind Hormonal Agency™. We look at symptoms, risk, labs, sleep, metabolism, sexual health, medication history, and treatment goals together. We discuss FDA-approved hormone therapy when appropriate, nonhormonal options when preferred or needed, and local vaginal therapy when symptoms are tissue-specific.

Hormone Therapy Is Not the Whole Answer, But It May Be the Missing One

Some women do not need hormone therapy. Some cannot use it. Some prefer nonhormonal treatment. Some need vaginal therapy rather than systemic therapy. Some need metabolic treatment, thyroid care, sleep care, pelvic floor care, or mental health support more urgently.

But some women are doing everything “right” and still suffering because estrogen withdrawal is driving their symptoms. They are lifting weights, eating protein, meditating, drinking less, and sleeping badly because night sweats keep waking them. They are told to optimize, but no one has offered menopause treatment.

That is where physician-managed care matters. Hormone therapy decisions should account for age, years since menopause, uterus status, route, dose, personal risk, family history, bleeding history, blood pressure, cardiovascular risk, clot risk, and patient goals. The plan should be monitored and adjusted.

For women who are not candidates for hormone therapy, evidence-based nonhormonal options still exist. The point is not that every woman should take hormones. The point is that every woman deserves real options.

How Hormonal Agency Builds a Whole-Person, Evidence-Based Plan

Hormonal Agency™ is built for women who are tired of both dismissal and overpromising. We do not reduce your symptoms to stress. We also do not sell the fantasy that a lab panel can explain your entire life. We start with a physician-managed evaluation and build from there.

Your plan may include menopause hormone therapy, progesterone when indicated, local vaginal therapy, nonhormonal treatment, thyroid or metabolic evaluation, protein targets, resistance training, alcohol reduction, sleep strategy, cardiometabolic labs, or coordination with hormone replacement therapy for women, Weight Loss Concierge, or menopause care.

The difference is accountability. If a treatment does not work, we reassess. If a symptom does not fit, we investigate. If risk changes, the plan changes. If labs matter, we use them.

That is the standard women should expect: care that listens deeply, thinks broadly, and still respects evidence.

Ready to get your hormones right?

Hormonal Agency™ gives you physician-managed hormone care built around your symptoms, risks, labs, sleep, metabolism, and goals.

Explore Hormonal Agency™

Agency Rx $149/mo | Complete $249/mo | Total $349/mo

100% Virtual • HSA/FSA Accepted • Board-Certified OB/GYN

Reader Exclusive: Use code HORMONESFIRST at checkout for $50 off your first month. Or take the 2-minute hormone quiz.

Frequently Asked Questions

Is functional medicine useful for menopause?

It can be useful when it prompts a broader review of sleep, nutrition, stress, metabolic risk, thyroid disease, medications, alcohol, and patient goals. It becomes unsafe when broad labs, supplement protocols, or root-cause language replace evidence-based menopause diagnosis and treatment.

Do menopause hormone labs prove what treatment I need?

Not by themselves. In many women over 45, menopause and perimenopause are diagnosed mainly from age, cycle changes, and symptoms because hormone levels fluctuate. Targeted labs can help rule in or rule out thyroid disease, anemia, diabetes risk, lipid risk, vitamin deficiencies, or medication safety concerns, but a lab panel should not replace clinical judgment.

Is compounded bioidentical hormone therapy safer than FDA-approved hormone therapy?

Major medical organizations do not consider compounded bioidentical hormone therapy safer or more effective than FDA-approved hormone therapy when an approved option is available. Compounded products may vary in dose, purity, labeling, and oversight, so they require careful physician discussion.

What should a physician-managed menopause plan include?

A physician-managed plan should review symptoms, menopause timing, uterus status, bleeding history, breast and clot risk, cardiovascular risk, medications, sleep, sexual and urinary symptoms, metabolic health, targeted labs, treatment eligibility, monitoring, and patient preference.

When should I seek evidence-based menopause care instead of another supplement plan?

Seek medical care when hot flashes, night sweats, insomnia, vaginal dryness, painful sex, urinary symptoms, mood changes, low libido, weight changes, bleeding after menopause, or bone-density concerns affect your life. Supplements should not delay evaluation for treatable menopause symptoms or medical conditions.

Dr. Shweta Patel, Board-Certified OB/GYN

Dr. Shweta Patel, MD, FACOG

Board-certified OB/GYN, U.S. Navy veteran, and founder of Gaya Wellness. Dr. Patel leads physician-managed programs in hormone optimization, menopause care, metabolic health, and longevity medicine for women in midlife and beyond.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing hormone therapy, prescription medication, supplement, or treatment program. Individual risks vary, and menopause care should be personalized to symptoms, medical history, contraindications, screening status, and current clinical guidance.

© 2026 Gaya Wellness PLLC | gayawellness.com | Dr. Shweta Patel, Board-Certified OB/GYN

You have not failed. Your plan did.

Hormonal Agency™

Your Hormones. Your Rules. Your Doctor.

The only board-certified OB/GYN-led virtual hormone program with quarterly labs included, video visits, and testosterone prescribed. Three tiers from $149/month.

✓ Board-Certified OB/GYN ✓ Quarterly Labs Included ✓ Testosterone Prescribed ✓ HSA/FSA Accepted